Objectives: Standard transabdominal CVS (TA-CVS) may be difficult due to axial-retroverted uterus, a posterior low-lying placenta with interposed bowel or uterine myomas, and alternative approaches are required. We analysed our series of difficult CVS procedures to evaluate the effectiveness of the percutaneous transvesical approach (TV-CVS) . Methods: Retrospective analysis of patients with difficult CVS, in which a secondary evaluation was required. Abdominal pressure or vaginal manipulation of the cervix were applied to enable the TA-CVS. If this was not possible, TV-CVS was indicated and a full bladder was required. The TV-CVS technique was performed free-hand transabdominally with ultrasound-guided insertion of a 15-cm/17-gauge Chiba needle, under local anesthesia. The needle entered the bladder and then the placenta parallel to its longest axis to sample by continuous aspiration with a 20-mL syringe. Results: A total of 1182 CVS procedures were performed in our centre from 2009 to 2015. In 95 (8.0%) cases the procedure was considered difficult, however a secondary evaluation achieved exposure or adequate sampling window with successful TA-CVS in 45 (47.3%) cases whereas in 50 (52.6%) cases a TV-CVS was performed. In our series of TV-CVS procedures, an adequate sample (>10 mg) was retrieved in all cases with single placental pass. There were: two (4.0%) cases of light postprocedure bleeding, two (4.0%) cases with vasovagal response, one (2.0%) with small subcutaneous hematoma and in another (2.0%) there was a failure of the long-term villi culture, no cases of hematuria or lower urinary tract disorders.
In the total group of 1182 CVS procedures, there were five miscarriages (1/236 of those with no TOP) at 12-24 weeks with none among the 50 patients undergoing TV-CVS. Conclusions: In our experience TV-CVS appears effective and it may be essential in specific high-risk cases in which the TA-CVS sampling window is obstructed. Lower urinary tract infection may impair cell culture growth, however this may be less relevant using microraray techniques. Objectives: To determine the risk factors associated with intrauterine demise (IUD) of one or both twins with Twin-twin transfusion syndrome (TTTS) treated by endoscopic Laser ablation of the superficial vascular anastomoses. Methods: A single-centre cohort study of twin pregnancies complicated by TTTS and treated by Laser. Data from the pre-Laser ultrasound scans, antenatal records, and post-treatment follow-up scans were collected. Pregnancies complicated by major structural anomalies, TAPS, loss-to-follow-up, and repeat Laser procedures were excluded from the analysis. The primary outcome measure was IUD of one or both twins. Results: 280 pregnancies were included in the analysis. The median gestational age at treatment was 19.7 weeks (IQR: 17.7-22.2 weeks). The survival rates of at least one and of both twins were 74.4% and 52.8%, respectively. Donor survival was significantly lower than recipient twin (54.3% vs 67.2%, P=0.001). 
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Selective reduction in complex triplet pregnancy by radio frequency ablation: single centre experience the use of intracardiac potassium chloride and fetal reduction must be performed using cord occlusion techniques such as bipolar cord coagulation, interstitial laser or by radiofrequency ablation. We present our series of selective reduction in complex triplet pregnancy with an MC pair using radiofrequency ablation (RFA). Methods: This was a retrospective study of the procedures in our unit for the period between 2010 and 2016. We had 25 cases of complex triplets (19 Dichorionic and 6 Monochorionic triplets). The indications for fetal reduction include 14 of multifetal pregnancy reduction, 9 cases of TTTs in the Monochorionic pair, 1 of fetal anomaly in co twin and 1 of discordant growth in the MC pair. Results: Outcome data was available in 24 cases. Median GA at procedure was 15.4 weeks (range 12.1-21.7) and at delivery was 32.9 weeks (range 17.4-41). We had 3 miscarriages; 2 cases occurred within 2 weeks of procedure. IUD of the co-twin occurred in 3 cases (2 in DCTA and 1 in MCTA). The median GA at delivery following MFPR in complex triplets was 34.6 weeks and in the TTTS group was 32.3 weeks.
Complications included complex thermal injury to the co twin in 1 case resulting in the subsequent termination of the co twin. There were no cases of neurological impairment in the survivors post procedure. Conclusions: This is the largest case series of fetal reduction in complex triplets by RFA. Selective reduction by RFA in complex triplet pregnancies resulted in a total pregnancy loss in 12.5% of the cases with an 87.5% favourable outcome, in other words two live babies at discharge from hospital. The gestational age was higher at delivery in the MFPR group compared to other indications for selective fetal reduction.
This data is useful in appropriate counselling of complex triplex pregnancies.
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Procedure outcomes of embryo reduction and selective feticide with multifetal pregnancy to twin or singleton pregnancy: a retrospective study Objectives: To study the procedure related adverse events and the outcomes of women with multifetal pregnancy, defined as twin or more fetuses that was reduced to twin or singleton pregnancy at different gestational ages. Methods: We analysed retrospective data consisted of 382 multifetal pregnancy cases that underwent embryo reduction and selective feticide between 2006.12 and 2017.01. Out of total cases, 179 cases underwent early transvaginal selective embryo reduction (mean 7.6 weeks gestation) and 203 cases underwent selective feticide (mean 13.4 weeks gestation) with KCL injection in the vicinity of the fetal heart via transabdominal approach after ultrasound screening for nuchal translucency and anatomical defects. Procedure outcomes were compared between the two groups.
Results:
The results showed significant differences between 2 groups (embryo reduction vs. selective feticide) in incidence of procedure related adverse events. The percentage of women with all surviving fetuses after 4 weeks of procedure was significantly higher in selective feticide group (92.0% vs. 98.2%, p=0.009) and the percentage of women with overall procedure related pregnancy loss (defined one and two losses of fetuses after 4 weeks of procedure) was significantly less in selective feticide group (8.0% vs. 1.8%, p=0.009). Incidence of subchorionic hematoma defined by ultrasound after 1 and 4 weeks of the procedure was significantly higher in the embryo reduction group (1 week; 59.8% vs. 27.9% p<0.001, 4 weeks; 34.2% vs. 4.8% p<0.001).
Conclusions: Selective feticide group showed less incidence of procedure related adverse events, such as subchorionic hematoma and fetal loss compared to embryo reduction group. Although both procedures are accepted approach in multifetal pregnancy reduction, spontaneous demise of one fetus may occur after embryo reduction, and selective feticide has benefit in enabling chorionic villus sampling and ultrasound screening for nuchal translucency and anatomical defects before the procedure.
OP23.06
Time and temperature dependence of radiofrequency ablation in human placenta Objectives: As radiofrequency (RF) has been widely applied for tumour devascularisation especially in placental tumour, this study was designed to compare the effects of radiofrequency (RF) on fresh placenta in varying degrees of sustained time (Ts) and target temperature (Tp). Methods: 108pieces of fresh placentae were coagulated with a 2-cm RF needle at 60W in the organ bath. The vertical and horizontal diameters (Vd,Hd) of tissue coagulation visualised by ultrasound were measured and the affected area (Ar) was calculated. 
